Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Kallioniemi

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
The American Journal of Pathology|December 6, 2002
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcomeMatt van de Rijn, Charles M Perou, Rob Tibshirani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2017
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell DependenciesAnita Sveen, Jarle Bruun, Peter W Eide, et al.
European Urology|May 11, 2016
Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate CancerKhalid Saeed, Vesa Rahkama, Samuli Eldfors, et al.
Haematologica|August 24, 2019
Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell typesMuntasir M Majumder, Aino-Maija Leppä, Monica Hellesøy, et al.
American Journal of Hematology|February 24, 2021
The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemiaTian Mou, Yudi Pawitan, Matthias Stahl, et al.
NPJ Precision Oncology|March 25, 2023
Prediction model for drug response of acute myeloid leukemia patientsQuang Thinh Trac, Yudi Pawitan, Tian Mou, et al.
NPJ Precision Oncology|February 19, 2024
Delineating functional and molecular impact of ex vivo sample handling in precision medicineNona Struyf, Albin Österroos, Mattias Vesterlund, et al.
Plos Pathogens|February 19, 2016
Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic ReplicationGiuseppe Balistreri, Johanna Viiliäinen, Mikko Turunen, et al.
Journal of the National Cancer Institute|September 9, 2022
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune featuresTeijo Pellinen, Lassi Paavolainen, Alfonso Martín-Bernabé, et al.
Genome Biology|September 23, 2008
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissuesSami Kilpinen, Reija Autio, Kalle Ojala, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
The American Journal of Pathology|December 6, 2002
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcomeMatt van de Rijn, Charles M Perou, Rob Tibshirani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2017
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell DependenciesAnita Sveen, Jarle Bruun, Peter W Eide, et al.
European Urology|May 11, 2016
Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate CancerKhalid Saeed, Vesa Rahkama, Samuli Eldfors, et al.
Haematologica|August 24, 2019
Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell typesMuntasir M Majumder, Aino-Maija Leppä, Monica Hellesøy, et al.
American Journal of Hematology|February 24, 2021
The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemiaTian Mou, Yudi Pawitan, Matthias Stahl, et al.
NPJ Precision Oncology|March 25, 2023
Prediction model for drug response of acute myeloid leukemia patientsQuang Thinh Trac, Yudi Pawitan, Tian Mou, et al.
NPJ Precision Oncology|February 19, 2024
Delineating functional and molecular impact of ex vivo sample handling in precision medicineNona Struyf, Albin Österroos, Mattias Vesterlund, et al.
Plos Pathogens|February 19, 2016
Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic ReplicationGiuseppe Balistreri, Johanna Viiliäinen, Mikko Turunen, et al.
Journal of the National Cancer Institute|September 9, 2022
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune featuresTeijo Pellinen, Lassi Paavolainen, Alfonso Martín-Bernabé, et al.
Genome Biology|September 23, 2008
Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissuesSami Kilpinen, Reija Autio, Kalle Ojala, et al.
Pageof 19